Clinical Trial

EOI Block vs. TAP Block in Minimally Invasive Hepatectomy

Study acronym: EOIvsTAP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to compare the analgesic efficacy of two different ultrasound-guided nerve blocks-the External Oblique Intercostal (EOI) block and the Subcostal Transversus Abdominis Plane (TAP) block-in patients undergoing minimally invasive hepatectomy. All participants will receive standardized general anesthesia and perioperative care at Seoul National University Hospital. Following anesthesia induction, patients will be randomly assigned to receive either an EOI block or a subcostal TAP block with 0.375% ropivacaine to provide regional pain relief. Postoperative pain will be managed using a combination of scheduled non-opioid analgesics and a fentanyl-based patient-controlled analgesia (PCA) device. The primary objective is to evaluate which regional technique more effectively reduces cumulative opioid consumption during the first 24 hours after surgery. Additionally, the study will assess pain intensity using the Numerical Rating Scale (NRS), the incidence of postoperative nausea and vomiting, and the overall recovery profile, including the time to first ambulation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-22.
Trial Details
NCT Number NCT07615231
Lead Sponsor Seoul National University Hospital
Conditions Hepatectomy
Enrollment 140 participants
Start Date 2026-06-01
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-08